Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkers.

Related Articles

Apocrine carcinoma of the breast: A brief update on the molecular features and targetable biomarkers.

Bosn J Basic Med Sci. 2017 Feb 21;17(1):9-11

Authors: Vranic S, Feldman R, Gatalica Z

Abstract
Apocrine carcinoma of the breast is a rare, primary breast cancer characterized by the apocrine morphology, estrogen receptor-negative and androgen receptor-positive profile with a frequent overexpression of Her-2/neu protein (~30%). Apart from the Her-2/neu target, advanced and/or metastatic apocrine carcinomas have limited treatment options. In this review, we briefly describe and discuss the molecular features and new theranostic biomarkers for this rare mammary malignancy. The importance of comprehensive profiling is highlighted due to synergistic and potentially antagonistic molecular events in the individual patients.

PMID: 28027454 [PubMed - indexed for MEDLINE]

http://ift.tt/2n8PuJM